Filings
Finds words inside filing documents. Searching LeonaBio, Inc.'s filings · 37 documents indexed.
19 documents · 54 matches
-
LONA LeonaBio, Inc. 10-Q 2026-08-14
Item 1A. Risk Factors.
tariff actions, and these tariffs were rescinded on February 24, 2026. Though guidance suggests that tariff refunds are forthcoming for entries10 matches in this document -
LONA LeonaBio, Inc. 10-K 2026-03-31
Item 1A. Risk Factors
tariff measures. Further tariffs may also be forthcoming following the initiation and completion of additional Section 301 tariff investigations. We cannot5 matches in this document -
LONA LeonaBio, Inc. 10-Q 2026-05-07
Item 1A. Risk Factors.
certain recent tariff actions, and these tariffs were rescinded on February 24, 2026. Though guidance suggests that tariff refunds are8 matches in this document -
LONA LeonaBio, Inc. 8-K/A 2025-12-18
tariffs on a number of countries. President Trump has directed various federal agencies to further evaluate key aspects of U.S. trade4 matches in this document -
LONA LeonaBio, Inc. 8-K 2025-12-18
tariffs on a number of countries. President Trump has directed various federal agencies to further evaluate key aspects of U.S. trade4 matches in this document -
LONA LeonaBio, Inc. 10-Q 2025-11-06
Item 1A. Risk Factors.
tariffs on a number of countries. President Trump has directed various federal agencies to further evaluate key aspects of U.S. trade4 matches in this document -
LONA LeonaBio, Inc. 10-Q 2025-08-07
Item 1A. Risk Factors.
tariffs on a number of countries. President Trump has directed various federal agencies to further evaluate key aspects of U.S. trade4 matches in this document -
LONA LeonaBio, Inc. 10-Q 2025-05-09
Item 1A. Risk Factors.
tariffs on a number of countries. President Trump has directed various federal agencies to further evaluate key aspects of U.S. trade4 matches in this document -
LONA LeonaBio, Inc. 8-K 2026-08-14
tariffs; the impact of competition; the impact of drug candidate development and clinical activities on operating expenses; the impact of new or changing1 match in this document -
LONA LeonaBio, Inc. 8-K 2026-05-07
tariffs; the impact of competition; the impact of drug candidate development and clinical activities on operating expenses; the impact of new or changing1 match in this document -
LONA LeonaBio, Inc. 8-K 2026-03-26
tariffs; the impact of competition; the impact of drug candidate development and clinical activities on operating expenses; the impact of new or changing1 match in this document -
LONA LeonaBio, Inc. 8-K 2026-03-26
tariffs; the impact of competition; the impact of drug candidate development and clinical activities on operating expenses; the impact of new or changing1 match in this document -
LONA LeonaBio, Inc. 8-K 2026-01-09
tariffs; the impact of competition; the impact of drug candidate development and clinical activities on operating expenses; the impact of new or changing1 match in this document -
LONA LeonaBio, Inc. 8-K/A 2025-12-18
tariffs; the impact of competition; the impact of drug candidate development and clinical activities on operating expenses; the impact of new or changing1 match in this document -
LONA LeonaBio, Inc. 8-K/A 2025-12-18
tariffs; the impact of competition; the impact of drug candidate development and clinical activities on operating expenses; the impact of new or changing1 match in this document -
LONA LeonaBio, Inc. 8-K 2025-12-18
tariffs; the impact of competition; the impact of drug candidate development and clinical activities on operating expenses; the impact of new or changing1 match in this document -
LONA LeonaBio, Inc. 8-K 2025-12-18
tariffs; the impact of competition; the impact of drug candidate development and clinical activities on operating expenses; the impact of new or changing1 match in this document -
LONA LeonaBio, Inc. 8-K 2025-11-06
tariffs; the impact of competition; the impact of drug candidate development and clinical activities on operating expenses; the impact of new or changing1 match in this document -
LONA LeonaBio, Inc. 8-K 2025-08-07
tariffs; the impact of competition; the impact of drug candidate development and clinical activities on operating expenses; the impact of new or changing1 match in this document
Page 1 of 1 · 19 documents